Page 9 - B Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novel EABR technology enhances potency and breadth of vaccine-induced responses through antigen presentation.

MyJournals.org - Science - 'IJMS, Vol. 24, Pages 8638: Identification of a Novel Linear B-Cell Epitope of HbpA Protein from Glaesserella parasuis Using Monoclonal Antibody' (International Journal of Molecular Sciences)

Treatment considerations for relapsing multiple myeloma is discussed by key opinion leaders.

Patients will survive for more than five years. so we really need to improve that. things have been getting a bit better with immuno therapies, but the immuno therapies which reactivate the immune system gets cancer relying on the t cells and we had thought that b cells, which are thought to more typically involve attacking viruses and bacteria were involved in targeting cancers, so it's a big shift in thinking and with a lie was to alter the way we think about immunotherapy and how we develop immunotherapy. you could eventually use this, hopefully they create a vaccine to prevent the cancer i...

A new tool that can uncover the developmental history of certain immune cells is now freely available worldwide. The tool provides insights into the stages that immune cells go through in a healthy individual and how this can be impacted in disease.